申请人:Hangzhou DAC Biotech Co., Ltd.
公开号:US10399941B2
公开(公告)日:2019-09-03
A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a Formula (I), wherein T, L, m, n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
强效细胞毒剂与细胞表面受体结合分子的共轭物具有式(I),其中 T、L、m、n、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12 和 R13 在本文中定义,可用于癌症、自身免疫性疾病和传染性疾病的靶向治疗。